People can argue all day about whether Illumina has, at last, given us the $1,000 genome. The answer does matter, because the cheaper it gets to sequence a whole human genome, the easier it will be to gather lots of them. That will help us understand what makes people different, and shed light on what causes disease. Or so scientists hope.
It’s heady stuff. But that’s the not the biggest story at Illumina right now.
{iframe}http://www.xconomy.com/national/2014/02/03/the-1k-genome-so-what-illumina-is-on-a-quest-for-world-domination/{/iframe}